Effectiveness of letters to patients with or without Cochrane blogshots on 10-year cardiovascular risk change among women in menopausal transition: 6-month three-arm randomized controlled trial

[1] Buljan I(2020)Comparison of blogshots with plain language summaries of Cochrane systematic reviews: a qualitative study and randomized trial Trials. 21 426-1248

[2] Tokalic R(1997)The burden of cardiovascular disease mortality in Europe Eur Heart J. 18 1231-1293

[3] Roguljic M(2012)The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomized controlled trial BMC Cardiovasc Disord. 12 17-510

[4] Zakarija-Grkovic I(2016)Cardiovascular disease in women: clinical perspectives Circ Res. 118 1273-1340

[5] Vrdoljak D(2005)National study of physician awareness and adherence to cardiovascular disease prevention guidelines Circulation. 111 499-eS17

[6] Milic P(2016)An update on gender disparities in coronary heart disease care Curr Atheroscler Rep. 18 28-2381

[7] Sans S(2006)Preventing cardiovascular disease in women Am Fam Physician. 74 1331-819

[8] Kesteloot H(2011)Getting patients to their lipid targets: a practical approach to implementing therapeutic lifestyle changes J Am Osteopath Assoc. 111 eS13-528

[9] Kromhout D(2016)The Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J 37 2315-1396.e6

[10] Ijzelenberg W(2004)Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol. 44 810-333

[1] Buljan I(2020)Comparison of blogshots with plain language summaries of Cochrane systematic reviews: a qualitative study and randomized trial Trials. 21 426-1248

[2] Tokalic R(1997)The burden of cardiovascular disease mortality in Europe Eur Heart J. 18 1231-1293

[3] Roguljic M(2012)The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomized controlled trial BMC Cardiovasc Disord. 12 17-510

[4] Zakarija-Grkovic I(2016)Cardiovascular disease in women: clinical perspectives Circ Res. 118 1273-1340

[5] Vrdoljak D(2005)National study of physician awareness and adherence to cardiovascular disease prevention guidelines Circulation. 111 499-eS17

[6] Milic P(2016)An update on gender disparities in coronary heart disease care Curr Atheroscler Rep. 18 28-2381

[7] Sans S(2006)Preventing cardiovascular disease in women Am Fam Physician. 74 1331-819

[8] Kesteloot H(2011)Getting patients to their lipid targets: a practical approach to implementing therapeutic lifestyle changes J Am Osteopath Assoc. 111 eS13-528

[9] Kromhout D(2016)The Sixth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur Heart J 37 2315-1396.e6

[10] Ijzelenberg W(2004)Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol. 44 810-333